Key Insights

Highlights

Treatment Research

7 treatments under study, led by Poba

Research Leaders

13 sponsors active, led by Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 6 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Not Yet Recruiting3
Active Not Recruiting1
Unknown1
Recruiting1

Clinical Trials (6)

Research Network

Common Treatments

  • Poba1
  • Drug Balloon Dilated1
  • Atorvastatin1
  • Balloon Dilated1
  • Alirocumab1

Active Sponsors

  • Shanghai Jiao Tong University Affiliated Sixth People's Hospital2
  • First People's Hospital of Hangzhou1
  • The First Affiliated Hospital of Zhengzhou University1
  • The Affiliated Hospital of Qingdao University1
  • Beijing Geriatric Hospital1

Top Investigators

Related Conditions

  • Stroke2

Activity Timeline